PAR
PARA BIO FPO [PAR]
Healthcare · ASX Small Cap
$0.2570 +0.8%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical58
Catalyst67
Sentiment50
Fundamental48
Momentum46
Risk Gate50
Get alerts when PAR's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Bollinger Bands are tightening — volatility is coiling up for a potential breakout
- Drifting lower — down 4.8% over the last 5 days
- Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
- Low cash runway (2 quarters) - dilution risk
- Very high P/S ratio (13689.5x)
- Strong revenue growth (+51%)
- EPS estimates revised downward (-6pts)
- Near 52-week low (8% of range)
- Revenue declined -290% YoY
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +51% — the top line is moving in the right direction
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.32%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about PAR
3 free messages/day · Unlimited with Pro
Recent Catalysts
HIGH Hong Kong Site Activated for Phase 3 OA Study
NONE Application for quotation of securities - PAR
NONE Appendix 4D and Half Year Report
NONE Change of Director's Interest Notice
Recent ASX Announcements
| 2026-03-19 | Hong Kong Site Activated for Phase 3 OA Study |
| 2026-03-16 | Application for quotation of securities - PAR |
| 2026-02-26 | Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-23 | Change of Director's Interest Notice |
| 2026-02-23 | Change of Director's Interest Notice |
Key Metrics
$115.7M
Market Cap
881K
Avg Volume
0.9x
Vol Ratio
$0.24 — $0.48
52-Week Range
0.4%
Short Interest
N/A
Cash Runway
-180.2%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 85% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | weak | Inst: 6% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #40 of 117 · Sector avg: 46
View all Healthcare signals →Track PAR and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required